Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.25474 | 85 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.01757 | 82 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.75529 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 9.60823 | 97 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.11565 | 83 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.74882 | 82 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.43145 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.89369 | 82 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.22025 | 84 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.77328 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.45927 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.2112 | 83 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.84703 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.5543 | 79 |